UB Paderborn / Katalog / Suche / in CDI

Active GPIIb-IIIa conformations that link ligand interaction with cytoskeletal reorganization

Blood, 2000-10, Vol.96 (7), p.2487-2495

2000

Link zum Volltext

Verfügbarkeit prüfen

Restoration of in vitro responses in platelets stored in plasma

American journal of clinical pathology, 1999-05, Vol.111 (5), p.693-699

1999

Link zum Volltext

Verfügbarkeit prüfen

Liquid cold storage of platelets: A revitalized possible alternative for limiting bacterial contamination of platelet products

Transfusion medicine reviews, 1997-10, Vol.11 (4), p.286-295

1997

Link zum Volltext

Verfügbarkeit prüfen

Increased expression of phosphatidylinositol‐specific phospholipase C resistant prion proteins on the surface of activated platelets

British journal of haematology, 1998-10, Vol.103 (1), p.276-282

1998

Link zum Volltext

Verfügbarkeit prüfen

Summary of a workshop on in vivo efficacy of transfused platelet components and platelet substitutes

Transfusion (Philadelphia, Pa.), 2000-06, Vol.40 (6), p.742-750

2000

Link zum Volltext

Verfügbarkeit prüfen

Peroxynitrite-Induced Tyrosine Nitration and Phosphorylation in Human Platelets

Free radical biology & medicine, 1997, Vol.22 (6), p.1055-1063

1997

Link zum Volltext

Verfügbarkeit prüfen

Biological action of nitric oxide donor compounds on platelets from patients with sickle cell disease

British journal of haematology, 2001-03, Vol.112 (4), p.1048-1054

2001

Link zum Volltext

Verfügbarkeit prüfen

Selective Induction of a Glycoprotein IIIa Ligand-Induced Binding Site by Fibrinogen and von Willebrand Factor

Blood, 1996-11, Vol.88 (10), p.3824-3830

1996

Link zum Volltext

Verfügbarkeit prüfen

Demographics of successful, unsuccessful and deferral visits at six blood centers over a 4-year period

Transfusion (Philadelphia, Pa.), 2012-04, Vol.52 (4), p.712-721

2012

Link zum Volltext

Verfügbarkeit prüfen

The potential impact of selective donor deferrals based on estimated blood volume on vasovagal reactions and donor deferral rates

Transfusion (Philadelphia, Pa.), 2010-06, Vol.50 (6), p.1265-1275

2010

Link zum Volltext

Verfügbarkeit prüfen

Toxicity of a first-generation adenoviral vector in rhesus macaques

Human gene therapy, 2002-01, Vol.13 (1), p.113-124

2002

Link zum Volltext

Verfügbarkeit prüfen

NHLBI plans for the promise of cell-based therapies

Cytotherapy (Oxford, England), 2005, Vol.7 (4), p.317-327

2005

Link zum Volltext

Verfügbarkeit prüfen

Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation

Human gene therapy, 2002-01, Vol.13 (1), p.125-128

2002

Link zum Volltext

Verfügbarkeit prüfen

Cold temperatures reduce the sensitivity of stored platelets to disaggregating agents

Platelets (Edinburgh), 2002, Vol.13 (1), p.11-20

2002

Link zum Volltext

Verfügbarkeit prüfen

Hemoglobin A0 and α-crosslinked hemoglobin (α-DBBF) potentiate agonist-induced platelet aggregation through the platelet thromboxane receptor

Artificial cells, blood substitutes, and immobilization biotechnology, 1998, Vol.26 (1), p.1-16

1998

Link zum Volltext

Verfügbarkeit prüfen

Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants

The New England journal of medicine, 2020-12, Vol.383 (27), p.2639-2651

2020

Link zum Volltext

Verfügbarkeit prüfen

Immunological Comparisons of Integrin α IIbβ 3 (GPIIb-IIIa) Expressed on Platelets and Human Erythroleukemia Cells: Evidence for Cell Specific Differences

Blood cells, molecules, & diseases, 1996, Vol.22 (1), p.23-35

1996

Link zum Volltext

Verfügbarkeit prüfen

Endogenous ADP prevents PGE1-induced tyrosine dephosphorylation of focal adhesion kinase in thrombin-activated platelets

Biochimica et biophysica acta, 1996-11, Vol.1314 (1-2), p.1

1996

Link zum Volltext

Verfügbarkeit prüfen

Timing of Red Blood Cell Transfusions and Occurrence of Necrotizing Enterocolitis: A Secondary Analysis of a Randomized Clinical Trial

JAMA network open, 2024-05, Vol.7 (5), p.e249643-e249643

2024

Link zum Volltext

Verfügbarkeit prüfen

Tissue Oxygenation Changes After Transfusion and Outcomes in Preterm Infants: A Secondary Near-Infrared Spectroscopy Study of the Transfusion of Prematures Randomized Clinical Trial (TOP NIRS)

JAMA network open, 2023-09, Vol.6 (9), p.e2334889-e2334889

2023

Link zum Volltext

Verfügbarkeit prüfen

Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery

The New England journal of medicine, 2011-12, Vol.365 (26), p.2453-2462

2011

Link zum Volltext

Verfügbarkeit prüfen

Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage

The New England journal of medicine, 2010-02, Vol.362 (7), p.600-613

2010

Link zum Volltext

Verfügbarkeit prüfen

The NHLBI SMARTT Program: A Novel Approach to Facilitate Translational Research for Heart, Lung and Blood Diseases

Circulation research, 2016-06, Vol.118 (12), p.1867-1871

2016

Link zum Volltext

Verfügbarkeit prüfen

Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program

Transfusion (Philadelphia, Pa.), 2015-03, Vol.55 (3), p.674-679

2015

Link zum Volltext

Verfügbarkeit prüfen

An Update from the United States National Heart, Lung, and Blood Institute‐funded Production Assistance for Cellular Therapies (PACT) Program: A Decade of Cell Therapy

Clinical and translational science, 2014-04, Vol.7 (2), p.93-99

2014

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Active GPIIb-IIIa conformations that link ligand interaction with cytoskeletal reorganization

Restoration of in vitro responses in platelets stored in plasma

Liquid cold storage of platelets: A revitalized possible alternative for limiting bacterial contamination of platelet products

Increased expression of phosphatidylinositol‐specific phospholipase C resistant prion proteins on the surface of activated platelets

Summary of a workshop on in vivo efficacy of transfused platelet components and platelet substitutes

Peroxynitrite-Induced Tyrosine Nitration and Phosphorylation in Human Platelets

Biological action of nitric oxide donor compounds on platelets from patients with sickle cell disease

Selective Induction of a Glycoprotein IIIa Ligand-Induced Binding Site by Fibrinogen and von Willebrand Factor

Demographics of successful, unsuccessful and deferral visits at six blood centers over a 4-year period

The potential impact of selective donor deferrals based on estimated blood volume on vasovagal reactions and donor deferral rates

Toxicity of a first-generation adenoviral vector in rhesus macaques

NHLBI plans for the promise of cell-based therapies

Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation

Cold temperatures reduce the sensitivity of stored platelets to disaggregating agents

Hemoglobin A0 and α-crosslinked hemoglobin (α-DBBF) potentiate agonist-induced platelet aggregation through the platelet thromboxane receptor

Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants

Immunological Comparisons of Integrin α IIbβ 3 (GPIIb-IIIa) Expressed on Platelets and Human Erythroleukemia Cells: Evidence for Cell Specific Differences

Endogenous ADP prevents PGE1-induced tyrosine dephosphorylation of focal adhesion kinase in thrombin-activated platelets

Timing of Red Blood Cell Transfusions and Occurrence of Necrotizing Enterocolitis: A Secondary Analysis of a Randomized Clinical Trial

Tissue Oxygenation Changes After Transfusion and Outcomes in Preterm Infants: A Secondary Near-Infrared Spectroscopy Study of the Transfusion of Prematures Randomized Clinical Trial (TOP NIRS)

Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery

Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage

The NHLBI SMARTT Program: A Novel Approach to Facilitate Translational Research for Heart, Lung and Blood Diseases

Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program

An Update from the United States National Heart, Lung, and Blood Institute‐funded Production Assistance for Cellular Therapies (PACT) Program: A Decade of Cell Therapy

Suchergebnisse filtern